Advisor Group’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Advisor Group’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-4,203	Closed	-$52K	–	4946
2016 Q4	$52K	Buy	4,203 +203	+5%	+$2.44K	﹤0.01%	2600
2016 Q3	$55K	Buy	+4,000	New	+$40.2K	﹤0.01%	2477

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Advisor Group's ARIA Position: Q1 2017 in Review

Advisor Group sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 4,203 shares — an estimated $52K sold.

Advisor Group first reported a position in ARIA in Q3 2016 and held it in 2 quarters. The position peaked at $55K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Advisor Group reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Advisor Group sold 4,203 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $52K.
Advisor Group first reported a position in Ariad Pharmaceuticals Inc in Q3 2016 and held it in 2 quarters.
Advisor Group's Ariad Pharmaceuticals Inc position peaked at $55K in Q3 2016.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Advisor Group's 13F filing for Q1 2017, filed 15 May 2017.